Rodatristat clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How each study uses rodatristat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Altavant Sciences GmbH (5) · Karos Pharmaceuticals (1)
Studies
Open first, then newest update. How each study uses rodatristat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)CompletedPhase 2Altavant Sciences GmbHNCT04712669Written as rodatristat ethyl 300 mg tablet BIDHow we know
- Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the HeartCompletedPhase 1Altavant Sciences GmbHNCT05933447Written as Rodatristat EthylHow we know
- A Single and Multiple Dose of Rodatristat Ethyl in Healthy Adult Subjects to Evaluate the Effect of Food and SafetyCompletedPhase 1Altavant Sciences GmbHNCT05684640Written as Rodatristat EthylHow we know
- Multiple-Ascending Dose in Japanese Patients Bridging StudyCompletedPhase 1Altavant Sciences GmbHNCT05065359Written as Rodatristat Ethyl 300 mg BIDHow we know
- A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)TerminatedPhase 2Altavant Sciences GmbHNCT03924154Written as RVT-1201How we know
- Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585CompletedPhase 1Karos PharmaceuticalsNCT02746237Written as KAR5585 CapsulesHow we know
Codes
What other systems call rodatristat · ClinicalTrials.gg INT000729
- MeSH (NLM) C000621040rodatristatOne source NLM
- UNII (FDA) 91D8378G2VRODATRISTATConfirmed FDA, NLM
- NCI Thesaurus C171780RodatristatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000621040 | rodatristat | One source NLM |
| UNII (FDA) | 91D8378G2V | RODATRISTAT | Confirmed FDA, NLM |
| NCI Thesaurus | C171780 | Rodatristat | One source FDA |
Also registered as rodatristat ethyl (UNII 507FY6OL37).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.